I'm most interested in the side effects, or lack of, in the phase 2 PMS trial.
You only have to read the facebook posts on the daybue public site to see the problems that parents are having with GI issues. If NNZ-2591 can provide equal or (hopefully) considerably better results without GI issues, then the value of NNZ-2591 could be quite extraordinary.
JP stated at the AGM that the participants in the PMS trial weren't experiencing those problems - hopefully the final results confirm that point.
I'm most interested in the side effects, or lack of, in the...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.69 |
Change
1.980(9.56%) |
Mkt cap ! $2.814B | |||
| Open | High | Low | Value | Volume |
| $23.00 | $23.07 | $21.60 | $11.23M | 501.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 165 | $22.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.73 | 103 | 1 |
View Market Depth
| Last trade - 11.50am 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$22.78 |
Change
1.980 ( 10.1 %) |
||||
| Open | High | Low | Volume | ||
| $22.98 | $23.00 | $21.60 | 155402 | ||
| Last updated 12.10pm 27/05/2024 ? | |||||
| NEU (ASX) Chart |